Copper deficiency myeloneuropathy: a clue to clioquinol-induced subacute myelo-optic neuropathy?
Schaumburg
Herbert
H
Herskovitz
Steven
S
D000818:Animals; D002614:Chelating Agents / Q000009:adverse effects; D007464:Clioquinol / Q000009:adverse effects* / Q000378:metabolism; D003300:Copper / Q000172:deficiency* / Q000378:metabolism; D006801:Humans; D009413:Nerve Fibers, Myelinated / Q000378:metabolism / Q000473:pathology; D009900:Optic Nerve / Q000378:metabolism / Q000503:physiopathology; D009901:Optic Nerve Diseases / Q000139:chemically induced* / Q000378:metabolism* / Q000503:physiopathology; D013116:Spinal Cord / Q000378:metabolism / Q000503:physiopathology; D013118:Spinal Cord Diseases / Q000139:chemically induced* / Q000378:metabolism* / Q000503:physiopathology; D015032:Zinc / Q000009:adverse effects / Q000378:metabolism
D002614:Chelating Agents; D003300:Copper; D007464:Clioquinol; D015032:Zinc